|
MLEC
|
Moolec Science SA
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OLK
|
Olink Holding AB
|
US
|
NASDAQ
|
|
OMIC
|
Singular Genomics Systems, Inc.
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
US
|
NASDAQ
|
|
PEPG
|
PepGen Inc.
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
US
|
NASDAQ
|
|
PRME
|
Prime Medicine, Inc.
|
US
|
NASDAQ
|
|
PRPO
|
Precipio, Inc.
|
US
|
NASDAQ
|
|
PTN
|
Palatin Technologies, Inc.
|
US
|
AMEX
|
|
QGEN
|
Qiagen N.V.
|
US
|
NYSE
|
|
QSI
|
Quantum-Si
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
US
|
NASDAQ
|
|
SLN
|
Silence Therapeutics Plc
|
US
|
NASDAQ
|
|
SQL
|
SeqLL Inc.
|
US
|
NASDAQ
|
|
SQZ
|
SQZ Biotechnologies Company
|
US
|
NYSE
|
|
TBIO
|
Telesis Bio, Inc.
|
US
|
NASDAQ
|
|
VNRX
|
VolitionRX Limited
|
US
|
AMEX
|